Pulsenmore Ltd.

PLSM ·Healthcare, Medical Devices
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025
Revenue $12.5M
Cost of Revenue $2.0M
Gross Profit $10.6M
Gross Margin 84.2%
Operating Expenses
Research & Development —
SG&A Expense —
Operating Income $-2.7M
Operating Margin -21.6%
Interest Expense $2.3M
Pretax Income $-5.0M
Income Tax Expense —
Net Income $-5.0M
Net Margin -39.6%
EPS (Basic) $0.77
EPS (Diluted) $0.77
Shares Outstanding (Basic) —
Shares Outstanding (Diluted) —
Dividends Per Share —